The largest database of trusted experimental protocols

11 protocols using vegf b

1

Western Blot and Immunostaining Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-Pan-Actin (#4968), Anti-ERK1/2 (#9102), anti-pERK1/2 Thr 202/Tyr204 (#9101), anti-AKT (#4685), anti-pAKT Ser473 (#9271 all from Cell Signaling), anti-FATP3 (Proteintech 12943-1-AP), anti-FATP4 (Abnova H00010999-M01), anti-PKC-θ (BD Transduction lab 610089), anti-Na,K ATPase A1 (Novus Biologicals NB300-146SS) and anti-HIBADH (Proteintech 13466-1-AP) antibodies were used for Western blot (1:1000 dilution). Anti-Occludin-1 (Abcam ab31721) and anti-Calnexin (Thermo MA3-27) antibodies were used for immunostaining (1:200 dilution). Mitotracker® Red CMXRos (Cell Signaling 9082S) was used for mitochondria staining. Sulfo-N-succinimidyl Oleate (sc-208408) was purchased from Santa Cruz. Akt VIII (#124018) was purchased from Calbiochem. CHC (#5029) was purchased from Tocris. Recombinant VEGFA (#293-VE-010) and VEGFB (#767-VE-010) were purchased from R&D systems. Human insulin (Humulin R U-100) was purchased from Harvard Drug Group (#821501). Membrane filters (MWCO 3 kDa #Z677094), Calcimycin (#C9275), 2,4-Dinitrophenol (#D198501), 2-deoxyglucose (#D8375), activated charcoal (#C4386) and other chemicals were purchased from Sigma unless otherwise stated.
+ Open protocol
+ Expand
2

Isolation and Culture of Neonatal Murine Astrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cerebral cortices from neonatal mice (1–3 days) were dissected, carefully stripped of their meninges, digested with 0.25% trypsin-EDTA and DNAse I (1 mg/ml) for 15 mins, and dispersed to single-cell level by passing through a cell strainer (70 µm). The cell suspension was then cultured at 37 °C in humidified 5% CO2, 95% air on poly-L-Lysine (Sigma) precoated 75 cm2 cell culture flasks. Medium was replaced every 4–5 d. After 7–10 d cells reached confluence and astrocytes and microglia were isolated by mild trypsinization with Trypsin-EDTA (0.06%) as previously described 10 (link),16 (link),17 (link). Cells were >95% astrocytes as determined by staining with GFAP or GLAST, with less than 5% contamination of CD11b+ microglia cells (not shown). Conversely, microglia cultures stained CD11b+CD45lowLy6C1low >95%. After the isolation procedure, cells were further plated as required for the specific experiments. Concentrations of agents were 100 ng/ml for LPS (Sigma), 50 µg/ml for poly(I:C), 100 ng/ml for IL-1β, 50 ng/ml for TNF-α, 0.1 ng/ml TGF-α, 10 ng/ml VEGF-B (all R&D Systems), 50 µg/ml 3-Indoxyl-sulfate (Sigma), 100 nM NF-kB Blocker Bengamide B (Tocris). Unless otherwise indicated, RNA was isolated 24 hours after start of treatment. For Western Blot, cells were pretreated with I3S or vehicle for 24 h, thereafter LPS was added and protein prepared after 2 h.
+ Open protocol
+ Expand
3

Endothelial Cell Signaling Pathway Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture media and supplements were purchased from Invitrogen Life Technologies (Carlsbad, CA). Fetal bovine serum (FBS) was obtained from HyClone Laboratories (Logan, UT), and human bFGF and S1P were from Upstate Biotechnology (Lake Placid, NY). Human recombinant proteins including VEGF-A165, VEGF-B, EGF, PlGF, and VEGF receptor-2 (rhVEGFR-2) were obtained from R&D Systems (Minneapolis, MN). RLYE, fluorescein isothiocynate (FITC)-conjugated RLYE, and biotin-labeled RLYE were purchased from Peptron (Daejeon, South Korea). All peptides were dissolved in phosphate-buffered saline (PBS) or saline at a concentration of 15 mM as a stock solution. Antibodies for phospho-ERK (Thr-202/Tyr-204), phospho-Akt (Ser-473), phospho-p38 (Thr-180/Tyr-182), phospho-Src (Tyr-416), phosphor-VEGFR-2 (Tyr-1175), phospho-FAK (Tyr-925), ERK, FAK, VEGFR-2, and Akt were obtained from Cell Signaling Technology (Beverly, MA). Antibodies for phospho-eNOS (Ser-1177) and eNOS were purchased from BD Transduction Laboratories (San Diego, CA). Antibodies for VEGFR-1 and p38 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Bevacizumab was purchased from Roche (Basel, Switzerland). Thermanox disc was purchased from Nalge Nunc International (Naperville, IL).
+ Open protocol
+ Expand
4

Western Blot and Immunostaining Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-Pan-Actin (#4968), Anti-ERK1/2 (#9102), anti-pERK1/2 Thr 202/Tyr204 (#9101), anti-AKT (#4685), anti-pAKT Ser473 (#9271 all from Cell Signaling), anti-FATP3 (Proteintech 12943-1-AP), anti-FATP4 (Abnova H00010999-M01), anti-PKC-θ (BD Transduction lab 610089), anti-Na,K ATPase A1 (Novus Biologicals NB300-146SS) and anti-HIBADH (Proteintech 13466-1-AP) antibodies were used for Western blot (1:1000 dilution). Anti-Occludin-1 (Abcam ab31721) and anti-Calnexin (Thermo MA3-27) antibodies were used for immunostaining (1:200 dilution). Mitotracker® Red CMXRos (Cell Signaling 9082S) was used for mitochondria staining. Sulfo-N-succinimidyl Oleate (sc-208408) was purchased from Santa Cruz. Akt VIII (#124018) was purchased from Calbiochem. CHC (#5029) was purchased from Tocris. Recombinant VEGFA (#293-VE-010) and VEGFB (#767-VE-010) were purchased from R&D systems. Human insulin (Humulin R U-100) was purchased from Harvard Drug Group (#821501). Membrane filters (MWCO 3 kDa #Z677094), Calcimycin (#C9275), 2,4-Dinitrophenol (#D198501), 2-deoxyglucose (#D8375), activated charcoal (#C4386) and other chemicals were purchased from Sigma unless otherwise stated.
+ Open protocol
+ Expand
5

Visualizing VEGFR Expression in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were stimulated with either VEGF-A (50 ng/ml; R&D Systems, Minneapolis, MN) or VEGF-B (50 ng/ml; R&D Systems, Minneapolis, MN) for 15 min. Following stimulation, cells were fixed in 4% paraformaldehyde for 15 min. Fixed cells were then washed 3 times in PBS, blocked (2% BSA, 2.5% donkey serum in PBS) for 1h at room temperature and incubated overnight with 1:200 dilution of rat anti-VEGFR1 (R&D Systems, Minneapolis, MN) or rabbit anti-VEGFR2 antibody (Proteintech, Rosemont, IL) at 4˚C. Cells were washed 3 times in PBS and incubated at room temperature for 1 hour with 1:400 dilution of AlexaFluor488-conjugated goat anti-rat IgG (Life Technologies, Carlsbad, CA) or donkey anti-rabbit Cy3 secondary antibody at 1:500 dilution (Jackson Immunoresearch Laboratories, West Grove, PA). Cells were washed 3 times with PBS and mounted in Vectashield mounting medium with DAPI (Vector labs, Burlingame, CA). Immunofluorescence analysis was performed using 40X and 63X objectives on a Zeiss 710 Confocal Microscope and Zen Imaging Software (version 2.1; Carl Zeiss, GmbH, Hamburg, Germany) located in the UIC-Ophthalmology Imaging Research Core.
+ Open protocol
+ Expand
6

Corpus Callosum Demyelination Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naive mice were anaesthesized and injected stereotaxically into the corpus callosum (1.4 anterior, 1.0 lateral, 2.1 mm deep) with 2 µl of Lysolecithin (1% w/v, Sigma), VEGF-B (500 ng, R&D Systems), or PBS. Mice were sacrificed 6 days later and subjected to myelin staining as described below.
+ Open protocol
+ Expand
7

Production and Characterization of VEGF-C mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
VEGF-C-mRNA (Extended Data Fig 2) was made by TriLink BioTechnologies (San Diego, CA), with full substitution of pseudo-uridine and 5-methyl-cytosine bases, capped using CleanCap™ AG and polyadenylated (120A). mRNA was mixed at a ratio of 1μg / 0.1μL of in vivo-jetPEI (Polyplus transfection, France) and vortexed for 30 seconds and incubated in room temperature for 15 minutes before use. Control mRNA (Cy5 labeled GFP, GFP-mRNA; Luciferase, Luc-mRNA) was also purchased from TriLink Biotechnologies. Recombinant proteins (VEGF-A, VEGF-B, VEGF-C Cys156Ser, VEGF-D) were purchased from R&D systems.
+ Open protocol
+ Expand
8

Production and Characterization of VEGF-C mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
VEGF-C-mRNA (Extended Data Fig 2) was made by TriLink BioTechnologies (San Diego, CA), with full substitution of pseudo-uridine and 5-methyl-cytosine bases, capped using CleanCap™ AG and polyadenylated (120A). mRNA was mixed at a ratio of 1μg / 0.1μL of in vivo-jetPEI (Polyplus transfection, France) and vortexed for 30 seconds and incubated in room temperature for 15 minutes before use. Control mRNA (Cy5 labeled GFP, GFP-mRNA; Luciferase, Luc-mRNA) was also purchased from TriLink Biotechnologies. Recombinant proteins (VEGF-A, VEGF-B, VEGF-C Cys156Ser, VEGF-D) were purchased from R&D systems.
+ Open protocol
+ Expand
9

Endothelial Differentiation of HemSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce endothelial differentiation, HemSCs (types 165 and 167) were seeded on fibronectin-coated plates at a density of 20,000 cells/cm2 in EGM-2. After 18–24 hours, the medium was replaced with serum-free EBM-2 containing 10 ng/mL VEGF-B (R&D Systems), 1× insulin transferrin-selenium, 1:5000 linoleic acid–albumin, 1 mM dexamethasone, and 60 mM ascorbic acid–2–phosphate (68 (link)). A stock solution of 10 mM propranolol hydrochloride (MilliporeSigma), R(+) propranolol hydrochloride (MilliporeSigma), atenolol (MilliporeSigma), and R(+) atenolol (MilliporeSigma) was prepared in DMSO (MilliporeSigma). Cells were cultured in the VEGF-B, serum-free media, with or without the indicated drugs, at a concentration of 5 μM propranolol, atenolol, and their R(+) enantiomers for 8 days. DMSO without VEGF-B served as a negative control and DMSO with VEGF-B as a positive control.
+ Open protocol
+ Expand
10

Western Blot Analysis of Angiogenic Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted from the lysed samples of mouse TG or cultured neurons in RIPA buffer. Samples (total protein concentration: 40 μg for mouse TG and corneal tissue or10 μg for cultured neurons) were run on 12% SDS-PAGE gels and then transferred to a PVDF membrane (Millipore, Billerica, MA). The blots were blocked with 5% non-fat dry milk for 1 h at room temperature and incubated overnight at 4 °C with primary antibodies, including VEGF-B (1:500; R&D),VEGFR-1 (1:1000; Abcam), NRP-1 (1:1000; Abcam), p-Akt (1:2000; Abcam), Akt (1:5000; Abcam), p-ERK (1:1000; CST), ERK (1:1000; CST) p-GSK3β (1:2000; CST), GSK3β (1:2000; CST), p-mTOR(1:1000, CST), mTOR(1:1000, CST), p-S6K (1:2000; CST), S6K (1:2000; CST) and GAPDH (1:3000; Abcam). Finally, the blots were incubated with the horseradish peroxidase-conjugated secondary antibody (1:3000; Amersham Biosciences, Piscataway, NJ) and visualized via the enzyme-linked chemiluminescence using the ECL kit (Chemicon, Temecula, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!